that high serum IL-6 correlated with dysfunctional CD8+ T cells in patients with renal cell carcinoma and that inhibition of IL-6 signaling alleviated the break on effector cell differentiation in tumor-bearing mice.54 The gene discussed is CD8A; the disease is renal cell carcinoma.